. | . |
Poodle Cloned In South Korea
Seoul (AFP) Jan 24, 2007 South Korean scientists who created the world's first cloned dog, an Afghan hound, have now cloned a poodle, a news report said Wednesday. The Korea Times quoted a source as saying that a team led by Professor Lee Byung-Chun cloned a poodle bitch midway through last year at the College of Veterinary Medicine of Seoul National University (SNU). The team had previously cloned one male and three female Afghan hounds. "The poodle puppy is the world's fifth dog clone and the first other than Afghan hounds. This marks another breakthrough in animal cloning," said the source. Researchers at Seoul National University declined to comment on the report. Science and Technology Minister Kim Woo-Sik said on Monday that the SNU team had cloned other animals in addition to the Afghan hounds and wolves. "The university asked me not to disclose some other cloning feats, which they said are possible only in Korea," the minister told journalists. He did not elaborate. Lee's team said in July last year that they had succeeded in cloning two females of an endangered species of wolf and had sent a research paper to scientific journals. But the feat was largely dismissed and the paper was rejected because Lee had worked with disgraced cloning expert Hwang Woo-Suk. The SNU team created the world's first cloned dog, Snuppy, in early 2005 under the stewardship of Hwang, who also claimed to have cloned patient-specific stem cells. After much of Hwang's research work was proved early last year to be bogus, all of the team's work came under suspicion. But several tests confirmed that the canine cloning was genuine. Hwang, who was hailed as a national hero until a university inquiry ruled his work was fake, is now on trial for fraud, embezzlement, ethical breaches and other charges. He has insisted he can still prove he created the first cloned human stem cells.
Source: Agence France-Presse Related Links Darwin Today At TerraDaily.com
Stem Cell Buzz May Help Industry Washington (UPI) Jan 17, 2007 Stem cell companies may benefit from the buzz surrounding the field generated by the anticipated clash between Congress and President Bush and increased regulatory attention being given to adult stem cell products. Companies focused on embryonic stem cell therapeutics have issued releases about their research recently in an apparent attempt to capitalize on the increased attention on the field after the House passed legislation last week that would relax restrictions on federal funding for the research. |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |